DioGenix

DioGenix, Inc., based in Gaithersburg, Maryland, specializes in the discovery, development, and commercialization of non-invasive molecular diagnostic tests. The company focuses on creating innovative tools for diagnosing early-stage multiple sclerosis (MS), categorizing MS patients into clinical sub-types, and predicting treatment responses through blood tests. Founded in 2007, DioGenix aims to enhance the capabilities of neurologists by providing effective clinical tests that improve patient care in the realm of neurology. As of September 2008, it operates as a subsidiary of Nerveda, Inc.